WBA - Walgreens Boots Alliance, Inc.


11.01
-0.020   -0.182%

Share volume: 6,347,847
Last Updated: 04-25-2025
Retail/Retail – Drug & Proprietary Stores: 0.07%

PREVIOUS CLOSE
CHG
CHG%

$11.03
-0.02
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
37%
Profitability 24%
Dept financing 49%
Liquidity 15%
Performance 53%
Company vs Stock growth
vs
Performance
5 Days
1.29%
1 Month
-0.81%
3 Months
-2.91%
6 Months
16.63%
1 Year
-37.80%
2 Year
-68.37%
Key data
Stock price
$11.01
P/E Ratio 
0.00
DAY RANGE
$10.95 - $11.03
EPS 
-$7.09
52 WEEK RANGE
$8.08 - $18.83
52 WEEK CHANGE
-$38.90
MARKET CAP 
9.212 B
YIELD 
9.36%
SHARES OUTSTANDING 
864.738 M
DIVIDEND
$0.25
EX-DIVIDEND DATE
08-21-2024
NEXT EARNINGS DATE
06-26-2025
BETA 
0.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,269,534
AVERAGE 30 VOLUME 
$13,701,545
Company detail
CEO: Rosalind G. Brewer
Region: US
Website: walgreensbootsalliance.com
Employees: 325,000
IPO year: 1985
Issue type: Common Stock
Market: XNAS
Industry: Retail/Retail – Drug & Proprietary Stores
Sector: Retail Trade

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products. The International segment operates 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, Republic of Ireland, the Netherlands, Mexico, and Chile.

Recent news
loading